Medicare Enrolled
Dr. Christos Bovetas, M.D.
Internal Medicine · Corona, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bovetas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bovetas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bovetas
Dr. Christos Bovetas is an internal medicine specialist in Corona, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bovetas performed 2,105 Medicare services across 1,112 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bovetas received a total of $7,330 from 50 pharmaceutical and/or device companies across 441 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bovetas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in CA
$7,330 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,105
Medicare services
Top 15% in CA for internal medicine
1,112
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~111 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
623 | $59 | $184 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
257 | $83 | $261 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
212 | $0 | $2 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
182 | $133 | $263 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
122 | $11 | $29 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
120 | $0 | $1 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
117 | $43 | $116 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
78 | $83 | $168 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
69 | $1 | $45 |
| Annual alcohol misuse screening, 5 to 15 minutes | 64 | $16 | $16 |
| Annual depression screening | 50 | $19 | $37 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
48 | $10 | $30 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
37 | $1 | $20 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
34 | $7 | $11 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
32 | $2 | $5 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
14 | $44 | $145 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
13 | $170 | $334 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
11 | $169 | $421 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
11 | $228 | $509 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
11 | $27 | $54 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,330
Total received (2018-2024)
Avg $1,047/year across 7 years
Top 12% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
441
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,330 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,368
2023
$1,114
2022
$1,072
2021
$1,307
2020
$1,017
2019
$827
2018
$625
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$375
Novo Nordisk Inc
$222
AstraZeneca Pharmaceuticals LP
$138
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$106
Almatica Pharma LLC
$95
Astellas Pharma US Inc
$68
Lilly USA, LLC
$63
Novartis Pharmaceuticals Corporation
$62
GlaxoSmithKline, LLC.
$53
ABBVIE INC.
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$36
Bayer Healthcare Pharmaceuticals Inc.
$36
PFIZER INC.
$29
Hologic Sales and Service, LLC
$22
Esperion Therapeutics, Inc.
$16
Top 3 companies account for 53.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,673
AstraZeneca Pharmaceuticals LP
$907
Novo Nordisk Inc
$625
Merck Sharp & Dohme Corporation
$481
AbbVie Inc.
$388
GlaxoSmithKline, LLC.
$309
Boehringer Ingelheim Pharmaceuticals, Inc.
$291
Biohaven Pharmaceuticals, Inc.
$239
Lilly USA, LLC
$239
Novartis Pharmaceuticals Corporation
$232
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$192
PFIZER INC.
$149
Biohaven Pharmaceutical Holding Company Ltd.
$147
Astellas Pharma US Inc
$105
ABBVIE INC.
$103
Janssen Pharmaceuticals, Inc
$97
Almatica Pharma LLC
$95
Eisai Inc.
$94
Takeda Pharmaceuticals U.S.A., Inc.
$80
E.R. Squibb & Sons, L.L.C.
$59
CVRx, Inc.
$58
Bayer Healthcare Pharmaceuticals Inc.
$58
Mylan Specialty L.P.
$50
Allergan, Inc.
$50
Allergan Inc.
$46
Esperion Therapeutics, Inc.
$41
Bausch Health US, LLC
$39
Smith+Nephew, Inc.
$38
Sunovion Pharmaceuticals Inc.
$35
Merck Sharp & Dohme LLC
$28
DERMIRA, INC.
$28
SI-BONE, Inc.
$27
Amarin Pharma Inc.
$24
MannKind Corporation
$23
Xeris Pharmaceuticals, Inc.
$23
Medtronic, Inc.
$22
Hologic Sales and Service, LLC
$22
Edwards Lifesciences Corporation
$19
Shire North American Group Inc
$19
ARBOR PHARMACEUTICALS, INC.
$19
Dexcom, Inc.
$19
AbbVie, Inc.
$19
Antares Pharma, Inc.
$17
Circassia Pharmaceuticals Inc
$17
SANOFI-AVENTIS U.S. LLC
$17
Tolmar, Inc.
$15
Ferring Pharmaceuticals Inc.
$14
Abbott Laboratories
$13
Synergy Pharmaceuticals Inc
$13
SANOFI PASTEUR INC.
$13
Top 3 companies account for 43.7% of all-time payments
Associated products mentioned in payments ›
ADACEL · AFREZZA · AIRSUPRA · ANORO · ANORO ELLIPTA · APLENZIN · AREXVY · Aimovig · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · Barostim Neo System · CHANTIX · CREON · DEXCOM CGM · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EUFLEXXA · EVENITY · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FREESTYLE LIBRE 2 · GARDASIL 9 · GATTEX · GRAFIX · GVOKE PFS · Horizant · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · LEQVIO · LINZESS · LONHALA MAGNAIR · LOREEV XR · MAZOR X SYSTEM · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NOCDURNA · NURTEC ODT · Otezla · Ozempic · PNEUMOVAX 23 · QBREXZA · QULIPTA · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Synthroid · TERIPARATIDE · THINPREP 2000 PROCESSOR · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · Trulance · UBRELVY · VIBERZI · VRAYLAR · VYNDAQEL · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · YUPELRI · Yupelri · ZEPBOUND · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
2,279
Per 100K population
93.0
County median income
$89,672
Nearest hospital
CORONA REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bovetas is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 12% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bovetas experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Bovetas performed 623 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bovetas receive payments from pharmaceutical companies?
Yes. Dr. Bovetas received a total of $7,330 from 50 companies across 441 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bovetas's costs compare to other internal medicine physicians in Corona?
Dr. Bovetas's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bovetas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Corona
Browse internal medicine physicians in Corona ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology